ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Repurposing FDA approved drugs targeting IL-6 associated signalling for the management of rheumatoid arthritis: an in silico and experimental approach.
Dhawal Jain et al.PubMed ↗Publisher ↗
No numbers read from the abstract.